chevron_leftBack
As of 15 June 2026, Fuan Pharmaceutical (Group) Co., Ltd. has a market cap of $726.89M USD, ranking #12695 globally and #3800 in China.
It ranks #1159 in the Healthcare sector, and #431 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$726.89MUSD
4.93B CNY
Enterprise Value
$687.82MUSD
4.65B CNY
Revenue (TTM)
$247.65MUSD
1.68B CNY
EBITDA (TTM)
$43.83MUSD
296.61M CNY
Net Income (TTM)
$9.28MUSD
62.86M CNY
EBITDA Margin
18%
Profit Margin
3.7%
PE Ratio
84.5
PS Ratio
2.9
PB Ratio
1.1
EV/EBITDA
15.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Lu Wang
open_in_new
Employees
3,392
Founded
2004
Website
fapharm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | 0.7% | 1% | -8.6% | -7.6% | 2.2% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300194
福安药业（集团）股份有限公司 Class A
ISIN: CNE1000011G4
Shares Out.:
Shares Outstanding:
1.19B1
Shares Float:
1.095B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
4.13 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Fuan Pharmaceutical (Group) Co., Ltd.
Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China. It offers APIs; intermediates; and FFPs, such as anti-tumor, generic drugs, antibiotics and oral, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. The company was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
7K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
7K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
4K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
105K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
75K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
50K%
|
97.4
|
|
SIX: RO
|
$321.52B
44K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
40K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
38K%
218.9B CHF
|
20.5
|
chevron_leftBack